Real-world Impact of 2-dose SARS-CoV-2 Vaccination in Kidney Transplant Recipients

Affiliations

¹ St Michael's Hospital Keenan Research Centre for Biomedical Science, Unity Health Toronto, Toronto, ON, Canada.
² University of Toronto Temerty Faculty of Medicine, Toronto, ON, Canada.
³ Applied Health Research Centre, Li Ka Shing Knowledge Institute, Toronto, ON, Canada.

Caitríona M McEvoy et al. Transplantation. 2022.

. 2022 May 1;106(5):e279-e280.

doi: 10.1097/TP.0000000000004081. Epub 2022 Mar 4.

¹ St Michael's Hospital Keenan Research Centre for Biomedical Science, Unity Health Toronto, Toronto, ON, Canada.
² University of Toronto Temerty Faculty of Medicine, Toronto, ON, Canada.
³ Applied Health Research Centre, Li Ka Shing Knowledge Institute, Toronto, ON, Canada.

No abstract available

Conflict of interest statement

The authors declare no conflicts of interest.

1. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206. - PMC - PubMed
1. Centers for Disease Control and Prevention. People with certain medical conditions. 2019. Available at https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-.... 2021. Accessed June 1, 2021.
1. Werbel WA, Boyarsky BJ, Ou MT, et al. Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Ann Intern Med. 2021;174:1330–1332. - PMC - PubMed
1. Kamar N, Abravanel F, Marion O, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661–662. - PMC - PubMed
1. Del Bello A, Abravanel F, Marion O, et al. Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients. Am J Transplant. 2022;22:322–323. - PMC - PubMed